A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT04866134 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04866134
- Sponsor
- Erasca, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-07
- Primary completion
- 2026-11-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.